The Autism Research Institute (ARI) is proud to be the only autism non-profit to be awarded the coveted 'Four Star Award" by Charity Navigator for sound fiscal management. ARI is even prouder of its unique track record in funding research projects which have made a real difference in discovering the true causes of autism, and developing effective treatments that bring about recovery from autism.
ARI-funded research has dispelled the conventional belief that autism is an untreatable lifelong disability. To see proof, please visit www.Autism-RecoveredChildren.org. ARI funds research intended to bring results, and not to demonstrate "political correctness." ARI funds research on controversial topics, such as the role of thimerosal in causing the autism epidemic -- topics ignored and avoided by the larger, mainstream organizations.
Thousands of parents and physicians world-wide credit the efforts of ARI with bringing recovery or near-recovery to their children and their patients.
Following is a small sample of recent ARI-funded "Research that makes a difference." (The research grants range from $300 To $100,000, with an average grant of $20,000).
Effective Treatments for Mercury and Lead Poisoning in Children: (1.) Development of Improved Versions of Current Medications; (2.) Development of New Medications James Adams, Ph.D., Dept. of Chemical and Materials Engineering, Arizona State University, Tempe, AZ
Vitamin/Mineral Abnormalities in Teens/Adults with Autism Spectrum Disorders James Adams, Ph.D., Dept. of Chemical and Materials Engineering, Arizona State University, Tempe, AZ
Identifying Effective Agents for Removing Mercury from the Brain H. Vasken Aposhian, Ph.D., U. of Arizona, Dept. of Molecular & Cellular Biology, Tucson, AZ
Gastrointestinal Manifestations of Autism / The Study of Intestinal Enzymology in Autistic Children Timothy Buie, M.D., Harvard/MassGeneral Hosp. for Children, Boston, MA
Epstein-Barr Virus as a Cause of Chronic Abdominal Pain in Children with Autism and Irritable Bowel Syndrome Anders Dahlstrom, M.D., Ph.D., Pediatric Gastroenterology, Mind Institute/Stanford University, Stanford, CA
Regulation of Methionine Synthase by Exogenous Methylcobalamin, Heavy Metals and TTFD Richard C. Deth, Ph.D., Northeastern University, Boston, MA
Role of Bacteria in Autoimmunity in Autism Sidney Finegold, M.D., Brentwood Biomed Research Institute, Los Angeles, CA
Synthesis and In Vivo Testing of New Mercury Chelators Based on Natural Compounds that Enter into Cells and Cross the Blood-Brain Barrier Boyd Haley, Ph.D., Professor & Chair U. of Kentucky, Dept. of Chemistry, Lexington, KY
Genetic and Metabolic Evidence for Increased Vulnerability to Oxidative Stress in Children with Autism S. Jill James, Ph.D., Professor Dept. of Pediatrics, ARK Children's Hospital Research Inst., Little Rock, AR
Immunological Reactions in Autistic Children Harumi Jyonouchi, M.D., University of Minnesota, Dept of Pediatrics, Minneapolis MN
Double Blind Dietary Intervention in Autistic Children Karl Reichelt, M.D., Ph.D., Pediatric Research Institute, Oslo, Norway
Autoimmunity Cytokines & Measles/MMR in Autism Vijendra K. Singh, Ph.D., Assoc. Prof. of Neuroimmunology Research, Utah State University, Department of Biology, Logan, UT
Diagnosis and Treatment of Gastrointestinal Disease in Autistic Children Andrew Wakefield, M.D., Thoughtful House, Austin, TX
A Pilot Study to Investigate the Biological Basis for Autistic Enterocolitis Steven Walker, Ph.D., Dept. of Physiology/Pharmacology, Winston-Salem, NC
Human Sulfotransferase Activity: Vitamin B6 Study Rosemary Waring, Ph.D., U. of Birmingham School Of Biochemistry, Birmingham, England
Mercury Levels in Intestinal Lining of Autistic Children Herbert Windom, Ph.D., University of Georgia, Skidway Institute
The Autism Research Institute is a 501(c)3 non-profit organization
Federal ID No. 95 254 8452 California Nonprofit No. 528668
All donations are appreciated and acknowledged.